Cargando…

RGD Peptide Modified Erythrocyte Membrane/Porous Nanoparticles Loading Mir-137 for NIR-Stimulated Theranostics of Glioblastomas

Cell-derived drug carriers have increasingly gained the interest of the scientific community due to their ability to imitate various natural properties of their source cells. We developed theranostics nanoplatforms composed of mesoporous silica nanoparticles (MSNs), indocyanine green (ICG) molecules...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Minghui, Cui, Xinyu, Wei, Feng, Li, Chao, Han, Xiaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105018/ https://www.ncbi.nlm.nih.gov/pubmed/35564173 http://dx.doi.org/10.3390/nano12091464

Ejemplares similares

Theranostic cRGD-BioShuttle Constructs Containing Temozolomide- and Cy7 For NIR-Imaging and Therapy
por: Wiessler, Manfred, et al.
Publicado: (2011)

NIR-Mediated drug release and tumor theranostics using melanin-loaded liposomes
por: Kim, Min Ah., et al.
Publicado: (2022)

Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent
por: Vatsa, Rakhee, et al.
Publicado: (2020)

Structural and process controls of AIEgens for NIR-II theranostics
por: Liu, Shunjie, et al.
Publicado: (2020)

iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma
por: Li, Huipu, et al.
Publicado: (2021)

NIR-II AIEgens with Photodynamic Effect for Advanced Theranostics
por: Yin, Shuai, et al.
Publicado: (2022)

miR-137 acts as a tumor suppressor via inhibiting CXCL12 in human glioblastoma
por: Li, Dehua, et al.
Publicado: (2017)

Recent advances in NIR-II fluorescence based theranostic approaches for glioma
por: Li, Jiaying, et al.
Publicado: (2022)

Internalisation of RGD-Engineered Extracellular Vesicles by Glioblastoma Cells
por: Gečys, Dovydas, et al.
Publicado: (2022)

Hybrid Theranostic Cubosomes for Efficient NIR-Induced Photodynamic Therapy
por: Bazylińska, Urszula, et al.
Publicado: (2022)

Preparation and evaluation of RGD and TAT co-modified docetaxel-loaded liposome
por: Zhu, Ren, et al.
Publicado: (2017)

LncRNA HAS2-AS1 Promotes Glioblastoma Proliferation by Sponging miR-137
por: Lu, Yalin, et al.
Publicado: (2021)

Au Hollow Nanorods-Chimeric Peptide Nanocarrier for NIR-II Photothermal Therapy and Real-time Apoptosis Imaging for Tumor Theranostics
por: Zhang, Weiyun, et al.
Publicado: (2019)

Hypoxia-Induced miR-137 Inhibition Increased Glioblastoma Multiforme Growth and Chemoresistance Through LRP6
por: Li, Dong-Mei, et al.
Publicado: (2021)

A miR-137-XIAP axis contributes to the sensitivity of TRAIL-induced cell death in glioblastoma
por: Geng, Fenghao, et al.
Publicado: (2022)

Advances in the Radiological Evaluation of and Theranostics for Glioblastoma
por: Hooper, Grayson W., et al.
Publicado: (2023)

TAT&RGD Peptide-Modified Naringin-Loaded Lipid Nanoparticles Promote the Osteogenic Differentiation of Human Dental Pulp Stem Cells
por: Zheng, Chun-Yan, et al.
Publicado: (2022)

Phenothiazine‐Biaryl‐Containing Fluorescent RGD Peptides
por: Ghabraie, Elmira, et al.
Publicado: (2020)

Size‐Dependent Cellular Uptake of RGD Peptides
por: Kemker, Isabell, et al.
Publicado: (2019)

New Methods for Labeling RGD Peptides with Bromine-76
por: Lang, Lixin, et al.
Publicado: (2011)

Fast Delivery of Multifunctional NIR‐II Theranostic Nanoaggregates Enabled by the Photoinduced Thermoacoustic Process
por: Xie, Huilin, et al.
Publicado: (2023)

Theranostic nanoparticles enhance the response of glioblastomas to radiation
por: Wu, Wei, et al.
Publicado: (2019)

miR-137: A New Player in Schizophrenia
por: Yin, Jingwen, et al.
Publicado: (2014)

Biodegradable Patches for Arterial Reconstruction Modified with RGD Peptides: Results of an Experimental Study
por: Sevostianova, Viktoriia V., et al.
Publicado: (2020)

RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy
por: Xu, Zichen, et al.
Publicado: (2023)

Low-Molecular Weight Polyethylenimine Modified with Pluronic 123 and RGD- or Chimeric RGD-NLS Peptide: Characteristics and Transfection Efficacy of Their Complexes with Plasmid DNA
por: Hu, Jing, et al.
Publicado: (2016)

Cellular Density Effect on RGD Ligand Internalization in Glioblastoma for MRI Application
por: Moncelet, Damien, et al.
Publicado: (2013)

Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies
por: Tang, Zhongyuan, et al.
Publicado: (2019)

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
por: Silber, Joachim, et al.
Publicado: (2008)

RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery
por: Wu, Dan, et al.
Publicado: (2019)

Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging
por: Shi, Jiyun, et al.
Publicado: (2016)

Synthesis of Novel Carborane-Containing Derivatives of RGD Peptide
por: Vakhrushev, Alexander V., et al.
Publicado: (2023)

Reduction of pluripotent gene expression in murine embryonic stem cells exposed to mechanical loading or Cyclo RGD peptide
por: Hazenbiller, Olesja, et al.
Publicado: (2017)

Preparation and evaluation of the anti-cancer properties of RGD-modified curcumin-loaded chitosan/perfluorohexane nanocapsules in vitro
por: Wang, Liang, et al.
Publicado: (2022)

The (95)RGD(97) sequence on the Aα chain of fibrinogen is essential for binding to its erythrocyte receptor
por: Carvalho, Filomena A, et al.
Publicado: (2018)

Preparation of RGD-modified Long Circulating Liposome Loading Matrine, and its in vitro Anti-cancer Effects
por: Liu, Xiao-yan, et al.
Publicado: (2010)

A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy
por: Li, Xiaoning, et al.
Publicado: (2018)

Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
por: Sun, Jiawei, et al.
Publicado: (2017)

Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer
por: Choi, Moon Jung, et al.
Publicado: (2023)

Development of iRGD-Modified Peptide Carriers for Suicide Gene Therapy of Uterine Leiomyoma
por: Egorova, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6hiq6ddu3ep2uv9rvdgh87845f